VIA
OGN icon

Vident Investment Advisory’s Organon & Co OGN Stock Holding History

Vident Investment Advisory’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,344
Closed -$290K – 1306
2023
Q1 		$290K Sell
12,344
-39,993
-76% -$1.07M 0.01% 965
2022
Q4 		$1.46M Buy
52,337
+3,160
+6% +$80.8K 0.06% 385
2022
Q3 		$1.11M Buy
49,177
+1,672
+4% +$50.5K 0.04% 561
2022
Q2 		$1.6M Buy
47,505
+12,770
+37% +$447K 0.05% 468
2022
Q1 		$1.21M Buy
+34,735
New +$1.19M 0.03% 620

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Vident Investment Advisory's OGN Position: Q2 2023 in Review

Vident Investment Advisory sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 12,344 shares — an estimated $290K sold.

Vident Investment Advisory first reported a position in OGN in Q1 2022 and held it in 5 quarters. The position peaked at $1.6M in Q2 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Vident Investment Advisory reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 12,344 Organon & Co shares in Q2 2023, an estimated $290K.
  • Vident Investment Advisory first reported a position in Organon & Co in Q1 2022 and held it in 5 quarters.
  • Vident Investment Advisory's Organon & Co position peaked at $1.6M in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.